Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may take a resolution of the Genzyme Corporation (NASDAQ: GENZ) merger, and a successful...
Published:
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news is not even on any of the...
Published:
Last Updated:
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc. (NASDAQ: AMGN) Started as Buy at Stifel Nicolaus. AngloGold...
Published:
Last Updated:
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has approached...
Published:
Last Updated:
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are...
Published:
Last Updated:
These are some of the major research calls we have seen from analysts in their upgrades, downgrades, and initiations so far this Monday: Amazon.com, Inc. (NASDAQ: AMZN) Raised to Conviction Buy List...
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls: Canadian National Railway Company (NYSE: CNI) Cut to Sector Peform at CIBC. Celgene...
Published:
Last Updated:
Thursday’s edition of the BioHealth Business Daily has many common companies through the biotech and pharma sectors, as well as some widely unknown names. We are seeing news reactions in shares...
Published:
Last Updated:
There are more recognized stocks in today’s edition of the BioHealth Business Daily. We are seeing significant and unusual moves, or implications, in shares of Celgene Corporation (NASDAQ: CELG),...
Published:
Last Updated:
Today’s wrap of the BioHealth Business Daily includes many less-covered stocks moving on news. We are seeing significant and unusual price changes in shares of Ardea Biosciences, Inc. (NASDAQ:...
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup. Aeropostale (NYSE:...
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls: AOL Inc. (NYSE: AOL) Started as Neutral at Goldman Sachs. BP plc (NYSE: BP) Raised to...
Published:
Last Updated:
These are this Tuesday’s top four day trader and active trader alert stories. We have more details and analysis via links to each story at VSInvestor.com: Celgene Corporation (NASDAQ: CELG) is...
Published:
Last Updated:
These are this Thursday morning’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amazon.com Inc. (NASDAQ: AMZN) Started as Market Perform at JMP Securities....
Published:
Last Updated:
These are the top 10 analyst upgrades, downgrades, and initiations we have seen early this Monday morning: Alliant Techsystems (ATK) Started as Buy at Jefferies. Celgene (CELG) raised to Outperform...
Published: